We demonstrate that FLRT2 elevates ACSL4 expression and subsequently facilitates lipid peroxidation and ferroptosis, thereby inhibiting the malignant phenotype of human bladder cancer cells. The gene discussed is FLRT2; the disease is urinary bladder cancer.